Cameco-backed Westinghouse Electric has filed confidentially for a potential IPO, a move that could ease Cameco's debt load and boost investor interest in nuclear stocks like NuScale Power and Fluor.
NASA has significantly more assets under management despite launching later, while ARKX concentrates 63% of its portfolio in industrials for defense-focused exposure.
ASP Isotopes (NASDAQ:ASPI) outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity’s 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
Chief Commercial Officer Viktor Petko
Annexon (NASDAQ:ANNX) said it expanded its pivotal ARCHER II trial of vonaprument in geographic atrophy, adding an independent 24-month dual primary endpoint alongside the study’s existing 15-month primary endpoint. The company said it remains confident in a planned fourth-quarter assessment of the
Humacyte (NASDAQ:HUMA) reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license application for dialysis access and begin a first-in-human coronary bypass study.
Commercial sales totaled
Boyd Group Services (TSE:BYD) reported second-quarter 2026 revenue above $1 billion for the first time, as the company expanded its footprint, integrated Joe Hudson’s Collision Center and advanced its Project 360 cost-transformation program.
Revenue rose 30% year over year to $1.013 billion, while
Acumen Pharmaceuticals (NASDAQ:ABOS) said it remains on track to report top-line results late in 2026 from its Phase II ALTITUDE-AD study of sabirnetug, an investigational antibody designed to selectively target synaptotoxic amyloid-beta oligomers in early Alzheimer’s disease.
Chief Executive Offic
SIL delivered 68% returns over one year but faced steeper drawdowns, while IAU's lower volatility and 0.25% expense ratio appeal to conservative investors seeking precious metals exposure.
Fastly shares jumped 27% after strong Q2 revenue and margin growth prompted analyst price target hikes and heavy institutional buying, though its high valuation remains a key risk.
Navigating the legal system after an arrest can be one of the most stressful experiences a person or family can face. In a close-knit community like Big La
Choosing the right diamond manufacturer can have a major impact on the success of a jewelry business. Whether you run an online jewelry store, a retail sho
BSV offers lower costs and higher yields for taxable investors, while VTES provides federal tax-free income for high-bracket earners seeking short-term bond exposure.
best mexican restaurants in ArubaIf you are visiting Aruba and craving tacos, burritos, quesadillas, margaritas, or other Mexican inspired dishes, you have
Cardiol Therapeutics (NASDAQ:CRDL) is advancing its synthetic, pharmaceutical-grade cannabidiol formulation, CardiolRx, in a pivotal Phase III trial for recurrent pericarditis, with management describing the program as a key step toward a potential new drug application.
Speaking at a Canaccord Genu
